四君子汤加减联合化疗对大肠癌术后患者CEA、CA199变化的影响

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:wn208001
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的研究分析四君子汤加减联合化疗对大肠癌术后患者癌胚抗原(CEA)和糖链抗原199(CA199)变化的影响。方法 68例行大肠癌术患者,随机分为观察组与对照组,各34例。观察组术后采用四君子汤辨证加减联合化疗,对照组仅采用化疗。观察并比较两组患者CEA、CA199变化。结果两组患者经化疗后,CEA以及CA199均有所下降,但观察组CEA、CA199较对照组降低更明显,差异均具有统计学意义(P<0.05)。结论大肠癌术后化疗时联合四君子汤,能明显降低CEA、CA199,值得推广应用。 Objective To study the effect of Si Junzi Decoction combined with chemotherapy on the changes of carcinoembryonic antigen (CEA) and carbohydrate antigen 199 (CA199) in postoperative patients with colorectal cancer. Methods 68 cases of colorectal cancer patients were randomly divided into observation group and control group, 34 cases each. The observation group was treated with Sijunzi decoction combined with chemotherapy and the control group only with chemotherapy. The changes of CEA and CA199 in both groups were observed and compared. Results After chemotherapy, CEA and CA199 decreased in both groups. However, CEA and CA199 in the observation group were significantly lower than those in the control group, with statistical significance (P <0.05). Conclusion Combined chemotherapy with Sijunzi Decoction for postoperative chemotherapy of colorectal cancer can significantly reduce CEA and CA199, which is worth popularizing and applying.
其他文献
酸感受离子通道(acid-sensing ion channels,ASICs)是一类由胞外酸化所激活的阳离子通道,属于真皮钠离子通道家族。至今已经克隆出这个家族7个不同亚基:ASIC1a;ASIC1b;ASIC1b2;ASIC2a
期刊
缺血性脑卒中是一个多因素诱发的中枢神经系统疾病,其病理机制主要涉及谷氨酸兴奋性毒性、自由基大量释放、脑内炎症应答和神经元坏死或凋亡等过程,它们互为因果、相互促进,最终导致患者中枢神经系统严重损伤,甚至造成死亡。该病具有高发病率、高死亡率和高复发率的特点,目前国内外仍无理想的治疗药物。故寻找高效、低毒、预后良好的缺血性脑卒中治疗药物显得尤为重要。近年来,由于缺血性脑卒中治疗药物存在的疗效单一、安全性
期刊
肝癌是最常见的消化系统恶性肿瘤之一,是广西常见和高发的恶性肿瘤。联合化疗是肝癌治疗的重要措施,但化疗效果不佳,除与70%肝癌天然耐药有关,MDR已成为肝癌治疗的最大障碍。
期刊
期刊
目的:探讨自身抗原牛胰岛素诱导免疫耐受防止1型糖尿病(T1D)模型小鼠发病的作用及其机制;研究体内树突状细胞(DC)及CD4~+CD25~+调节性T细胞在自身抗原胰岛素诱导T1D小鼠免疫
期刊
期刊